Corundum Group, Inc. - MYMD PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Corundum Group, Inc. ownership history of MYMD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,603
-60.5%
19,6000.0%0.01%
-53.3%
Q2 2023$29,400
-12.8%
19,6000.0%0.02%
-6.2%
Q1 2023$33,712
+146473.9%
19,6000.0%0.02%
+23.1%
Q4 2022$23
-100.0%
19,6000.0%0.01%
-59.4%
Q3 2022$51,000
+18.6%
19,6000.0%0.03%
+10.3%
Q2 2022$43,000
-52.7%
19,6000.0%0.03%
-65.9%
Q1 2022$91,000
-23.5%
19,6000.0%0.08%
+10.4%
Q4 2021$119,000
+46.9%
19,600
+74.4%
0.08%
+28.3%
Q3 2021$81,000
+14.1%
11,2400.0%0.06%
+27.7%
Q2 2021$71,00011,2400.05%
Other shareholders
MYMD PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
NorthRock Partners, LLC 1,354,004$9,749,0000.80%
Shay Capital LLC 197,184$1,420,0000.18%
Corundum Group, Inc. 11,240$81,0000.06%
Mirae Asset Global Investments Co., Ltd. 1,132,131$8,151,0000.02%
Patriot Financial Group Insurance Agency, LLC 500$4,0000.00%
MORGAN STANLEY 668,151$4,811,0000.00%
WELLS FARGO & COMPANY/MN 2,956$21,0000.00%
NORTHERN TRUST CORP 56,561$407,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 279$2,0000.00%
View complete list of MYMD PHARMACEUTICALS INC shareholders